NDAQ:CASI - Post Discussion
Post by
whytestocks on Mar 05, 2024 2:00pm
CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Cli
News; $CASI CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients | BenzingaCASI Pharmaceuticals Inc (NASDAQ:CASI) and BioInvent International AB announced preliminary efficacy data for BI-1206 in combination...
CASI - CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients | Benzinga
Be the first to comment on this post